A director at Wacker Chemie AG sold 2,969 shares at 100.651EUR and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
Having flirted with the 495-point mark on Friday, which could have triggered an extension of the correction, the market has rebounded well since then. Our technical analysis highlights a configuration in which we are only at the start of a powerful rally. Target of 622 points for Stoxx 600 index (+11%) by the end of the year confirmed. Prefer banks to insurance companies in the short term. - ...
Après avoir frôlé vendredi la barre des 495 points qui aurait pu déclencher la poursuite de la correction, le marché a ensuite bien rebondi. Notre analyse technique met en lumière une configuration où nous ne serions qu’au début d’un rallye puissant. Objectif 622 points (+11%) d’ici à la fin de l’année confirmé sur le Stoxx 600. Préférer les banques aux assurances à court terme. - ...
>Q1 EBITDA of € 172m 15% above consensus of € 150m, but operationally in line - Wacker Chemie reported Q1 group results, with sales of € 1,490m (css € 1,501m) down 15% y-o-y fuelled by a 9% drop in Chemicals (Silicones/Polymers), sales and prices driven 32% y-o-y (- 1% q-o-q), drop in PolySi sales. Group volumes improved 4% y-o-y in Q1 (Q4: -3%). Group EBITDA of € 172m (css/ODDO BHF € 150m/€ 145m) was 15% above the consensus (+8% at chemicals, -17% at PolySi) and up ...
As Spring approaches, we see industry-wide destocking coming to an end, emerging recovery trends in China gaining momentum and European spot energy cost relief rolling in, all helping to restore plant utilisation and earnings. We add more cyclicality to our preferred names, upgrading BASF to Outperform (Neutral). Momentum being regained in specialties chemicals distribution triggers our upgrade of IMCD to Outperform (Neutral). ‘From record to record’ remains our mantra at FUCHS. ...
>Final FY 2023 results in line with preliminaries - Final FY 2023 results confirmed the comprehensive preliminary results reported 29 January with EBITDA of € 824m dropping 60% y-o-y compared to € 2,081m reported in 2022. Preliminary Q4 2023 dropped 62% y-o-y to € 136m fuelled by all segments. FCF 2023 of € 166m declined from € 564m on lower earnings and despite strong NWC tailwind.Lower than expected € 3.00 dividend proposed - Wacker proposed a € 3.0...
>Implied Q4 EBITDA of € 136m -8% vs consensus; FCF of € 166m came in better on NWC relief - Wacker Chemie reported preliminary FY 2023 results. Group EBITDA of € 824m came in at the low end of the € 800-900m guidance range as flagged before, 1% below consensus of € 835m (ODDO BHF € 823m). Pronounced chemicals seasonality and continuing PolySI deterioration pushed EBITDA down by 11% q-o-q to €136m in Q4 2023 compared to € 152m in Q3, 8% below css (€ 147m) and in line w...
We host our 27th ODDO BHF Forum in Lyon in 11th and 12th January 2024 and virtually 15th and 16th January 2024. In total, 335 companies will be presenting. In the following note, we provide some initial feedback of the company on the last day (day 4). - ...
We host our 27th ODDO BHF Forum in Lyon in 11th and 12th January 2024 and virtually 15th and 16th January 2024. In total, 335 companies will be presenting. In the following note, we provide some initial feedback of the company on the last day (day 4). - ...
>Key takeaway from GIS conference: slow start to H1 2024 … - At our GIS conference, Wacker's CEO confirmed the outlook for 2023, i.e. EBITDA of € 800-900m (consensus at € 840m). Visibility on 2024 remains very limited with no strong indications on 2024 but warning of a slow start expected in 2024 as the order book is currently showing 'no signs of picking-up'. … headwinds from high-cost inventories still weighing on the silicone segment … - Wacker ...
>Q3 EBITDA of € 152m 4% below consensus - Wacker Chemie reported Q3 group results with sales of € 1,523m (css € 1,551m) down 29% y-o-y fuelled by 24% drop in Chemicals (Silicones/Polymers) sales and price driven 45% y-o-y (33% q-o-q) drop in PolySi sales. Group volumes declined 7% y-o-y in Q3, similar to Q2 2023. Group EBITDA of € 152m (css/ODDO BHF € 159m/€ 162m) was 4% below consensus (in-line at chemicals, lower biosolutions) and down by 41% q-o-q compared wit...
>Preliminary Q2 EBITDA of € 255m 4% below consensus on 'other', otherwise in line - Wacker Chemie reported preliminary group results, expecting sales of € 1,750m (consensus € 1,779m) and EBITDA of € 255m (consensus € 265m), with EBITDA down by 9% q-o-q compared with € 281m in Q1. Operational EBITDA excl. 'other' of € 281m was in line with consensus/ODDO of € 277m/€ 275m.Chemicals EBITDA -25% q-o-q on much weaker silicones beyond turnaround costs - Com...
In the middle of spring, we see industry-wide destocking continuing into Q2 and the emerging recovery trends in China still sending mixed signals at least partly offset by the prospect of European spot energy cost relief. This may help improve plant utilisation rates from trough levels going into the summer, though visibility remains low. We focus on self-help, support from SBBs or shareholder activism as key short-term drivers. We prefer Brenntag (Outperform on activist pressure...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.